CPB vs DOGZ Stock Comparison

Campbell'S and Dogness (International) Prices as of Oct 26, 2026 Peers: Industry group
CPB CAMPBELL'S Co
$20.63 +6.5% 1M -33.3% 1Y
Market cap
$6.15B
P/E
15.3x
Revenue (TTM)
$9.74B
Div. yield
6.88%
Packaged Foods Consumer Staples
4 wins

Head to Head

4 decided of 12

Campbell'S leads on 4 of the 12 questions below (Campbell'S 4). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCPBDOGZLeader
Larger companyMarket capitalisation $6.15B $12.64M CPB
Cheaper on earningsLower P/E, profitable companies only 15.3x -0.5x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 13.1x — –
Faster revenue growthRevenue growth, trailing twelve months -5.0% — –
More profitableNet margin, trailing twelve months 4.1% — –
Better return on capitalReturn on invested capital 5.9% — –
Less leveragedLower net debt / EBITDA 5.3x — –
Higher dividend yieldTrailing dividend yield 6.88% — –
Better 1-year returnPrice return, last 12 months -33.3% -94.1% CPB
Better 5-year returnAnnualised price return, 5 years -12.4%/yr -61.1%/yr CPB
Less volatileAnnualised volatility, 1 year 33.5% 172.3% CPB
Higher overall scoreMean of the five percentile scores vs peers 57/100 — –

Percentile Scorecard

CPBDOGZ

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCPBDOGZ
Valuation 77 #4 of 14 31 #10 of 14
Growth 27 #9 of 12 –
Profitability 89 #2 of 10 –
Financial Health 33 #11 of 16 93 #2 of 16
Shareholder Returns – –
Overall 57 –
  • CPB ranked among 16 companies in Branded Foods
  • DOGZ ranked among 16 companies in Branded Foods

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCPBDOGZSPY
1 month +6.5%-22.8% -0.8%
3 months -7.8%-22.8% +3.5%
6 months +0.4%-42.3% +7.0%
Year to date -26.0%-93.3% +12.2%
1 year -33.3%-94.1% +13.0%
3 years -49.0%-88.8% +86.3%
3 years, per year -20.1%-51.8% +23.1%
5 years -48.3%-99.1% +68.6%
5 years, per year -12.4%-61.1% +11.0%
10 years -61.6%— +258.0%
10 years, per year -9.1%— +13.6%

Risk

MeasureCPBDOGZSPY
Volatility, 1Y 33.5%172.3% 12.7%
Downside volatility, 1Y 35.7%225.1% 12.7%
Beta vs S&P 500, 1Y -0.380.53 1.00
Return / volatility, 1Y -0.99-0.55 1.02
Max drawdown, 5Y -67.2%-99.6% -25.4%
From 52-week high -34.8%-94.4% -1.8%
52-week high $31.66$12.71 $779.14
52-week low $18.90$0.71 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCPBDOGZ
P/E now vs peer median 15.3xmedian 12.2x -0.5xmedian 12.2x
P/S now vs peer median 0.6xmedian 0.6x 0.8xmedian 0.6x
EV/EBITDA now vs peer median 10.2xmedian 9.2x —median 9.2x
P/FCF now vs peer median 9.1xmedian 9.1x -1.6xmedian 9.1x
P/B now vs peer median 1.6xmedian 0.8x 0.2xmedian 0.8x
PEG now vs peer median -0.69median 0.18 —median 0.18

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCPBDOGZ
Revenue $9.74B –
Gross profit $2.74B –
Operating income $852.00M –
Net income $405.00M –
Free cash flow $678.00M –
R&D $99.00M –
EPS (diluted) $1.34 –
Cash & equivalents $394.00M $4.49M
Total debt $28.19B $16.00M
Shares (diluted) 300.00M 17.81M
Enterprise value $4.93B -$17.37M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCPBDOGZ
P/E 15.3x -0.5x
P/FCF 9.1x -1.6x
P/Operating cash flow 5.9x –
P/S 0.6x 0.8x
P/B 1.6x 0.2x
P/Tangible book -17.8x 0.2x
EV/EBITDA 10.2x –
EV/EBIT 15.1x –
EV/Revenue 1.3x –
EV/FCF 19.0x –
EV/Operating cash flow 12.4x –
PEG (3Y EPS CAGR) -0.69 –

Growth

14 metrics
MetricCPBDOGZ
Revenue growth (1Y) -5.0% –
Revenue CAGR (3Y) 1.4% –
Gross profit growth (1Y) -12.1% –
Gross profit CAGR (3Y) -2.0% –
Operating income growth (1Y) -24.2% –
Operating income CAGR (3Y) -13.4% –
Net income growth (1Y) -32.7% –
Net income CAGR (3Y) -22.1% –
EPS growth (1Y) -33.1% –
EPS CAGR (3Y) -22.2% –
Operating cash flow growth (1Y) -8.1% –
Operating cash flow CAGR (3Y) -3.1% –
Free cash flow growth (1Y) -3.8% –
Free cash flow CAGR (3Y) -4.3% –

Profitability

14 metrics
MetricCPBDOGZ
Gross margin 28.1% –
EBITDA margin 13.0% –
Operating margin 8.7% –
Pretax margin 5.4% –
Net margin 4.1% –
FCF margin 7.0% –
Operating cash flow margin 10.7% –
Return on equity 10.3% –
Return on assets 2.6% –
Return on invested capital 5.9% –
Return on capital employed 7.1% –
Asset turnover 0.6x –
Cash conversion (OCF / net income) 2.6x –
Stock comp / revenue 0.6% –

Financial Health

11 metrics
MetricCPBDOGZ
Debt / assets 45.6% 3.8%
Debt / equity 1.9x 0.0x
Net debt / EBITDA 5.3x –
Debt / FCF 10.5x –
Liabilities / assets 75.4% 20.3%
Equity / assets 24.6% 79.7%
Interest coverage 2.6x –
Current ratio 0.8x 1.1x
Quick ratio 0.3x 0.8x
Cash ratio 0.1x 0.6x
Altman Z-score 1.48 –

Shareholder Returns

7 metrics
MetricCPBDOGZ
Dividend yield 6.9% –
Net buyback yield 0.4% –
Shareholder yield 7.3% –
Payout ratio (earnings) 116.0% –
Payout ratio (FCF) 69.3% –
Dividend growth (1Y) 2.4% –
Dividend CAGR (3Y) 1.7% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCPBDOGZ
Forward P/E 13.1xFY2027 –
EPS, next fiscal year $1.58FY2027 –
EPS growth, next FY -27.2%FY2027 –
EPS growth, the year after +20.3% –
Revenue, next fiscal year $9.76BFY2027 –
Revenue growth, next FY +0.2%FY2027 –
Revenue growth, the year after +2.5% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCPBDOGZ
Held by institutions 61.7% –
Institutions holding 620 –
Change in shares held, QoQ +0.2% –
Institutions buying 388 –
Institutions selling 150 –
Buyers to sellers 2.59 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CPBDOGZ
CPB 1.00 -0.05
DOGZ -0.05 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CPB and DOGZ?

Campbell'S (CPB) is the largest by market capitalisation: Campbell'S (CPB) $6.15B, Dogness (International) (DOGZ) $12.64M.

Which stock has performed better?

Over the past year Campbell'S (CPB) returned the most: Campbell'S (CPB) -33.3%, Dogness (International) (DOGZ) -94.1%. Over five years, Campbell'S (CPB) compounded fastest (Campbell'S (CPB) -12.4%/yr, Dogness (International) (DOGZ) -61.1%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Campbell'S (CPB) 6.88%. Dogness (International) (DOGZ) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Campbell'S (CPB) has been the steadiest (Campbell'S (CPB) 33.5%, Dogness (International) (DOGZ) 172.3%). Volatility measures how widely the price swings, not the risk of the business.

Do CPB and DOGZ move together?

Their daily returns over the past year have a correlation of -0.05, a negative relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, CPB and DOGZ?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Campbell'S (CPB) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.